Mackay Shields LLC Natera, Inc. Transaction History

Mackay Shields LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$86.05 - $119.72 $1.97 Million - $2.74 Million	-22,900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $1.26 Million - $1.72 Million	-13,800 Reduced 37.6%	22,900 $2.33 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $346,632 - $581,048	-5,200 Reduced 12.41%	36,700 $3.65 Million
Q3 2020 Nov 04, 2020	SELL	$45.89 - $72.67 $188,149 - $297,947	-4,100 Reduced 8.91%	41,900 $3.03 Million
Q2 2020 Jul 31, 2020	BUY	$26.36 - $49.86 $15,816 - $29,916	600 Added 1.32%	46,000 $2.29 Million
Q1 2020 May 08, 2020	BUY	$17.27 - $40.17 $86,350 - $200,850	5,000 Added 12.38%	45,400 $1.36 Million
Q4 2019 Feb 11, 2020	SELL	$32.1 - $40.4 $109,140 - $137,360	-3,400 Reduced 7.76%	40,400 $1.36 Million
Q3 2019 Nov 01, 2019	BUY	$25.38 - $34.89 $1.11 Million - $1.53 Million	43,800 New	43,800 $1.44 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.